Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > LATEST
LATEST
-
BUSINESS Generic Makers Positive on New AG Pricing, Cite Gains in Productivity and Predictability
January 8, 2026
-
BUSINESS Bayer, University of Tsukuba Hospital Tie Up for Early Heart Failure Detection
January 8, 2026
-
BUSINESS Envudeucitinib Hits PIII Goals in Psoriasis, JNDA Planned for 2027: Kaken
January 8, 2026
-
BUSINESS Pharma Leaders Press for Drug Pricing Overhaul at New Year’s Confab
January 8, 2026
-
BUSINESS Generic Entry into DPP-4 Class Poised to Accelerate in 2026
January 7, 2026
-
BUSINESS Takeda Files Polycythemia Vera Drug Rusfertide in US
January 7, 2026
-
BUSINESS Daito Snags China Approval for Iguratimod, Its Third Product
January 7, 2026
-
BUSINESS China Accepts BLA for Leqembi Subcutaneous Autoinjector: Eisai
January 7, 2026
-
COMMENTARY Wave of “World Firsts” Looms as 47 New Drug Candidates Line Up for 2026
January 6, 2026
-
ORGANIZATION FY2026 Reform Tilted toward Price Cuts despite Spillover Scrap: FPMAJ Chair
January 6, 2026
-
ORGANIZATION Pfizer Japan President Igarashi Takes Helm as PhRMA Japan Chair
January 6, 2026
-
REGULATORY MHLW Issues Guidance on Revised PMD Act Ahead of May Enforcement
January 6, 2026
-
BUSINESS Kyorin Licenses Lasvic to UAE’s Lunatus for Middle East Markets
January 6, 2026
-
REGULATORY MHLW Sets Up Drug Discovery Support Office Ahead of New Fund Launch
January 6, 2026
-
BUSINESS Sanofi to Transfer Jevtana Sales to Taiho from April
January 6, 2026
-
REGULATORY Ex-JPMA President Ueno Takes on New AMED Advisor Role
January 6, 2026
-
REGULATORY Cabinet OKs FY2026 Tax Reform Package, Creates Strategic Tech R&D Credit
January 5, 2026
-
BUSINESS Meiji Restarts Domestic 6-APA Production after 31-Year Hiatus
January 5, 2026
-
REGULATORY Chuikyo OKs Medical Materials Reform Outline, Price Hikes Possible for Loss-Making Devices
January 5, 2026
-
ORGANIZATION Industry Leaders Call for Proper Rewards for Innovation in New Year Messages
January 5, 2026
ページ
As many as 47 new drug candidates are expected to win approval or secure NHI price listing in Japan in…
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…